• Epidemiology
• 37 min
  1. Assessment of obesity and classification of patients: historical perspectives and current practice

  • Prof. George Bray
• 40 min
  2. Epidemiology of obesity

  • Prof. Jacob Seidell
• Etiology and Causes
• 59 min
  3. Metabolic, adipose tissue and muscle predictors of obesity

  • Prof. Ian Macdonald
• 41 min
  4. Neural control of food intake and energy balance

  • Prof. Hans-Rudolf Berthoud
• 64 min
  5. Understanding obesity: genes and environment in the determination of body weight

  • Prof. Rudy Leibel
• 47 min
  6. Dietary determinants of obesity

  • Prof. Arne Astrup
• 42 min
  7. Physical inactivity as a determinant of obesity

  • Prof. Wim Saris
• 42 min
  8. Environmental causes of obesity: sociocultural, built environment and economic factors

  • Prof. Shiriki Kumanyika
• 29 min
  9. The developmental origins of obesity

  • Prof. David Barker
• Consequences of Obesity
• 46 min
  10. Obesity, dyslipoproteinemia and inflammation

  • Prof. Robert Eckel
• 23 min
  11. Pathophysiology and management of obesity related hypertension

  • Prof. Arya Sharma
• 22 min
  12. Disorders of overeating

  • Prof. Albert Stunkard
• 20 min
  13. Obesity, weight loss and health-related quality of life

  • Prof. Aila Rissanen
  • Dr. Jarmo Kaukua
• Treatment Options
• 44 min
  14. Lifestyle modification for weight control

  • Prof. Thomas Wadden
• 34 min
  15. Bariatric / obesity surgery

  • Prof. Henry Buchwald
• 48 min
  16. Can obesity be prevented in the current obesogenic environment?

  • Prof. Boyd Swinburn
• 28 min
  17. Pharmacotherapy for obesity: why it is needed

  • Prof. Joe Proietto
• 35 min
  18. Pharmacotherapy for obesity: hunger suppressors

  • Prof. Joe Proietto
• Latest Developments in the Field
• 60 min
  19. Body composition

  • Dr. Steven Heymsfield
• 56 min
  20. Adipose tissue metabolism and obesity

  • Dr. Max Lafontan
• 25 min
  21. Obesity, present and future therapies

  • Prof. Sir Stephen Bloom
• 42 min
  22. Energy expenditure in the lean and obese

  • Prof. Dale Schoeller
• 33 min
  23. Obesity and adiponectin

  • Prof. Philipp Scherer
• 44 min
  24. Ectopic fat: causes, consequences and treatment

  • Prof. Steven Smith
• 47 min
  25. Adipose-immune interactions in obesity

  • Dr. Vishwa Dixit
• 39 min
  26. Health benefits of intentional weight loss

  • Prof. Xavier Pi-Sunyer
• 39 min
  27. Childhood obesity: implications for current and future health

  • Prof. Peter T. Katzmarzyk
• 46 min
  28. The clinical assessment and management of child and adolescent obesity

  • Prof. Louise Baur
• Archived Lectures - These lectures may not cover the latest advances in the field
• 41 min
  29. Gastrointestinal peptides and food intake regulation

  • Prof. Sir Stephen Bloom
• 48 min
  30. Obesity and mortality: questions and controversy

  • Prof. David Allison
• 37 min
  31. Obesity, diabetes and the cluster of the metabolic syndrome

  • Prof. Peter Wilson
• 44 min
  32. New standards in weight management: recent and future drugs for the treatment of obesity

  • Prof. Luc Van Gaal
• 46 min
  33. Health economics of obesity: new insights

  • Dr. Anne Wolf
• 34 min
  34. Bariatric surgery: techniques and mechanisms of action

  • Prof. Walter Pories
• 39 min
  35. Childhood obesity: implications for future health

  • Prof. Peter T. Katzmarzyk
• 14 min
  36. Pharmacotherapy for obesity 1 - the need for pharmacotherapy in weight management

  • Prof. Joe Proietto
• 46 min
  37. Pharmacotherapy for obesity 2 - pharmacological agents in current use & under development

  • Prof. Joe Proietto

Printable Handouts

PDF

Navigable Slide Index

1. Introduction
2. Objectives
3. Health economics terminology (1)
4. Health economics terminology (2)
5. International estimates of the costs
6. Economic impact of obesity in different countries
7. USA cost of obesity
8. The direct cost of overweight and obesity 2004
9. Direct cost of chronic disease in the USA 2004
10. Costs of obesity comparing to other lifestyle isues
11. Health care costs by BMI category, 2000
12. Financial impact of obesity among older people
13. Annual per capita cost of obesity/age - men
14. Annual per capita cost of obesity/age - women
15. BMI is a predictor of future medical charges
16. Annual per capita cost of obesity/race - men
17. Annual per capita cost of obesity/race - women
18. Health care costs by degree of obesity
19. Greater percent increase in pharmaceutical use
20. Swedish obese subjects study
21. Medical spending (%) attributable to obesity
22. Private health insurance spending
23. Major cost drivers of obesity
24. The costs to the workplace
25. Estimated cost of obesity to U.S business in 1994
26. Obesity is associated with loss in productivity
27. Obesity is associated with rates of disability
28. Economic effect of obesity to business
29. Hours of productivity lost by health risk
30. Short term disability
31. Is treating obesity cost effective?
32. Criteria that make treatment justified
33. Criteria 2-5 for justifying treatment
34. Cost of obesity treatments
35. How do benefits compare with costs?
36. Life style intervention
37. Impact on daily medication use
38. Pharmacotherapy
39. Pharmaceutical cost savings
40. Pharmacotherapy decreases diabetes medication
41. Cost effectiveness frame work
42. Cost effectiveness of Xenical
43. Surgery
44. Weight loss by surgical intervention
45. Medication costs
46. Weight loss by surgical intervention - Sweden
47. Weight loss by surgical intervention - Canada
48. Weight loss by surgery may decrease sick leave
49. Conclusion

Topics Covered

• International cost estimates
• Benchmark cost estimates
• Direct cost in the US by demographics
• Impact on productivity
• Impact of weight loss on health care costs: lifestyle, pharmacotherapy and surgical interventions

Links

Series:

• Obesity

Categories:

• Clinical Practice
• Metabolism & Nutrition

Therapeutic Areas:

• Cardiovascular & Metabolic

Talk Citation

Publication History

• Published on October 1, 2007
• Archived on February 25, 2021

Financial Disclosures

• Dr. Anne Wolf has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.